The wait for the Covid-19 vaccine may be over soon, and according to sources, after the second phase of human trials of the vaccine in the country has passed, it is likely to be used on the frontline staff involved in the treatment of the coronavirus epidemic.
The human trials of India biotech vaccine Kovaxin made in the country will begin on Wednesday. Industry sources say that human trials of another vaccine involving coronavirus may begin in July. However, experts believe that even if the vaccine completes the third phase of clinical trials, it will still take at least a year to get marketing permission.
The first phase of testing primarily tests vaccine toxicity on a small population and typically takes a month or more. At the same time, its effect is seen in the second phase test and its dose is determined which may take about six months. If all goes well, some vaccines associated with Covid-19 may complete another level of human trials by the end of this year.
An industry source said, 'However, there is a possibility that after the completion of Phase II testing, at least the frontline staff, especially doctors and other health professionals, have no option of treatment in critical conditions. But the vaccine can be given. The source said that the information related to the vaccine's effect and its safety will be available from the second phase itself, and the third phase test can continue simultaneously. However, the local industry feels that even if the vaccine is used based on no other alternative, the vaccine will not be available before March next year.
A senior government official said that no decision has been taken yet. He said, 'We are closely monitoring the situation. It is important to protect the frontline employees. Also, plasma therapy is being used as a second option for serious patients and other trials are also underway. Therefore, we will take any decision at the right time only after the data related to human testing comes. But the safety of citizens is first.
Experts say this is an unprecedented situation. Rajiv Gandhi Biotechnology Center's Chief Scientific Officer E Srikumar says that the use of these drugs has been started in the event of no alternative and similarly these vaccines without approval should be used for high-risk groups. Can. Even if this happens, it can be considered only after the second phase of testing.
The industry believes that the vaccination campaign for the treatment of Covid 19 is a major task in the country. Even if only 10 percent of the country's population is vaccinated, it will still be 130 million doses. If two shots are needed in the vaccine, then it means that 26 crore doses will have to be produced. A vaccine manufacturer said it would take a few years before the whole of India is covered. This will be a huge task. The manufacturers believe that the Covid 19 vaccine will be a multiple shot vaccine.
Bharat Biotech has indicated that they will begin human trials from Wednesday and data on first phase trials will be introduced soon. However, the company has not given any deadline for this. On Monday, the company claimed that the Drug Controller General of India approved to start the first and second phase of human clinical trials when the company presented the results of pre-clinical (animal) studies that showed safety and immunity response. Gave it The SARS-COV-2 strain was separated into the National Institute of Virology, Pune, an institute under the Indian Council of Medical Research (ICMR) and transferred to Bharat Biotech. The fully indigenous, inactivated vaccine was developed at Bharat Biotech's Biosafety Level 3 plant in Hyderabad.
The race to produce the Covid 19 vaccine includes Cadila Healthcare in Ahmedabad, Rambana Biotech (with Rifana) in Delhi, and Serum Institute in Pune (along with AstraZeneca for the Oxford vaccine). Globally, Oxford-AstraZeneca, Moderna, and China's Synovac Biotech are also going to conduct large-scale trials in July. In this case, the competition will be very strong. Other sources in the industry say that the Drug Controller General of India has approved simultaneous Phase I and Phase II trials for the Bharat Biotech vaccine, indicating that the government also wants to speed it up.
Nitish Kumar will not campaign in UP, know who else did not get a place in the list of star campaigners of JDU
JDU Campaign In UP Election 2022: The election campaign in Uttar Pradesh has intensified. Meanwhile, Janata Dal-United (JDU) has submitted the list of its star campaigners to the Election Commission.
IND vs ENG: This player got a chance in the test series in place of Virat Kohli, news of joining the team in Hyderabad
The five-Test series between India and England is starting on Thursday (January 25). The first match between the two teams will be played at the Rajiv Gandhi International Stadium in Hyderabad.
Deoghar accident: When the breath was stuck for hours on the ropeway of death, the survivors told a painful scene
The rescue operation started after the Deoghar ropeway accident has ended. All the people trapped after the accident have been taken out. Those trapped in the accident have been admitted to the
PM Modi's important meeting with Amit Shah, Doval on Nagrota encounter, terrorists were planning a big attack on the anniversary of Mumbai attack
PM Modi held an important meeting on Friday after four suspected Jaish-e-Mohammed militants were killed in an encounter in Nagrota, Jammu, and Srinagar. In this meeting, along with PM Modi, Union Home
Jaishankar met families of 8 Indians who were sentenced to death in Qatar, and said to take all possible steps for their release
Jaishankar in Qatar External Affairs Minister S Jaishankar met the families of 8 Indians who were sentenced to death in Qatar. During the meeting, Jaishankar stressed that the Government of India is
Power Crisis: States did not pay Coal India's 21 thousand crore rupees, nor did they raise coal
To end the deepening power crisis in the country, several steps have been taken by the Central Government with immediate effect. Under this, while instructions have been given to increase coal
Team India's Possible Playing XI: Gill, Iyer, and Vihari can replace Pujara in the first Test against Sri Lanka.
The 2-match Test series between India and Sri Lanka is going to start from Friday. The first match will be played at the PCA Stadium in Mohali. After making a clean sweep in the T20 series, Team
Corona's havoc: Schools and colleges closed again in many states, know where and how long it will remain closed?
Once again, the global infectious epidemic coronavirus cases are seen increasing steadily. In recent times infections have increased wildly in many states. The reason for this, whether it is no longer
Rahul Gandhi said: Difference between Hinduism and Hindutva, the hate ideology of BJP-Sangh heavy on the Congress ideology of love-nationalism
Congress leader Rahul Gandhi on Friday inaugurated the party's digital 'Jan Jagran Abhiyan'. During this, he spoke in gestures and gestures regarding the ongoing controversy over the book of party
Mohammad Yousuf will take over the responsibility of permanent batting coach of the Pakistan team, which will be announced soon
The Pakistan Cricket Board (PCB) is all set to appoint its legendary batsman Mohammad Yousuf as the permanent batting coach of the Pakistan cricket team. Sources say that this decision comes after the
